# Forum Energy Technologies, Inc.: financial statements, quarterly

FET · NYSE · CIK 1401257 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fet.md) · [Financials](/companies/fet/financials.md) · [Filings](/companies/fet/filings.md) · [Insiders](/companies/fet/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fet/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [185](/filings/0001401257-24-000121.md) | [179](/filings/0001401257-24-000135.md) | [185 d](/filings/0001401257-25-000012.md) | [202](/filings/0001401257-25-000061.md) | [205](/filings/0001401257-25-000089.md) | [208](/filings/0001401257-25-000108.md) | [201 d](/filings/0001401257-26-000015.md) | [193](/filings/0001401257-26-000034.md) | [200](/filings/0001401257-25-000089.md) | [196](/filings/0001401257-25-000108.md) | [202 d](/filings/0001401257-26-000015.md) | [209](/filings/0001401257-26-000034.md) |
| Cost of revenue | $m | [134](/filings/0001401257-24-000121.md) | [128](/filings/0001401257-24-000135.md) | [135 d](/filings/0001401257-25-000012.md) | [139](/filings/0001401257-25-000061.md) | [142](/filings/0001401257-25-000089.md) | [142](/filings/0001401257-25-000108.md) | [139 d](/filings/0001401257-26-000015.md) | [135](/filings/0001401257-26-000034.md) | [140](/filings/0001401257-25-000089.md) | [156](/filings/0001401257-25-000108.md) | [141 d](/filings/0001401257-26-000015.md) | [148](/filings/0001401257-26-000034.md) |
| Gross profit | $m | [51.3](/filings/0001401257-24-000121.md) | [51.0](/filings/0001401257-24-000135.md) | [49.7 d](/filings/0001401257-25-000012.md) | [63.8](/filings/0001401257-25-000061.md) | [63.1](/filings/0001401257-25-000089.md) | [65.7](/filings/0001401257-25-000108.md) | [62.5 d](/filings/0001401257-26-000015.md) | [58.4](/filings/0001401257-26-000034.md) | [59.4](/filings/0001401257-25-000089.md) | [40.2](/filings/0001401257-25-000108.md) | [61.1 d](/filings/0001401257-26-000015.md) | [61.0](/filings/0001401257-26-000034.md) |
| Selling, general and administrative | $m | [44.4](/filings/0001401257-24-000121.md) | [45.5](/filings/0001401257-24-000135.md) | [45.0 d](/filings/0001401257-25-000012.md) | [54.7](/filings/0001401257-25-000061.md) | [53.7](/filings/0001401257-25-000089.md) | [56.3](/filings/0001401257-25-000108.md) | [54.6 d](/filings/0001401257-26-000015.md) | [49.4](/filings/0001401257-26-000034.md) | [51.2](/filings/0001401257-25-000089.md) | [50.4](/filings/0001401257-25-000108.md) | [48.9 d](/filings/0001401257-26-000015.md) | [50.0](/filings/0001401257-26-000034.md) |
| Operating income | $m | [6.4](/filings/0001401257-24-000121.md) | [5.7](/filings/0001401257-24-000135.md) | [1.8 d](/filings/0001401257-25-000012.md) | [3.2](/filings/0001401257-25-000061.md) | [7.9](/filings/0001401257-25-000089.md) | [8.9](/filings/0001401257-25-000108.md) | [(107) d](/filings/0001401257-26-000015.md) | [8.8](/filings/0001401257-26-000034.md) | [14.7](/filings/0001401257-25-000089.md) | [(6.1)](/filings/0001401257-25-000108.md) | [12.8 d](/filings/0001401257-26-000015.md) | [11.0](/filings/0001401257-26-000034.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [1.9](/filings/0001401257-24-000121.md) | [1.5](/filings/0001401257-24-000135.md) | [4.9 d](/filings/0001401257-25-000012.md) | [3.5](/filings/0001401257-25-000061.md) | [2.5](/filings/0001401257-25-000089.md) | [4.6](/filings/0001401257-25-000108.md) | [(3.7) d](/filings/0001401257-26-000015.md) | [3.8](/filings/0001401257-26-000034.md) | [6.2](/filings/0001401257-25-000089.md) | [10.1](/filings/0001401257-25-000108.md) | [6.2 d](/filings/0001401257-26-000015.md) | [2.9](/filings/0001401257-26-000034.md) |
| Net income | $m | [(6.6)](/filings/0001401257-24-000135.md) | [8.0](/filings/0001401257-24-000135.md) | [(16.8) d](/filings/0001401257-25-000012.md) | [(10.3)](/filings/0001401257-25-000108.md) | [(6.7)](/filings/0001401257-25-000108.md) | [(14.8)](/filings/0001401257-25-000108.md) | [(104) d](/filings/0001401257-26-000015.md) | [1.1](/filings/0001401257-26-000034.md) | [7.7](/filings/0001401257-25-000108.md) | [(20.6)](/filings/0001401257-25-000108.md) | [2.1 d](/filings/0001401257-26-000015.md) | [4.5](/filings/0001401257-26-000034.md) |
| Diluted EPS | $ per share | [(0.64)](/filings/0001401257-24-000121.md) | [0.77](/filings/0001401257-24-000135.md) | not reported | [(0.85)](/filings/0001401257-25-000061.md) | [(0.54)](/filings/0001401257-25-000089.md) | [(1.20)](/filings/0001401257-25-000108.md) | not reported | [0.09](/filings/0001401257-26-000034.md) | [0.61](/filings/0001401257-25-000089.md) | [(1.76)](/filings/0001401257-25-000108.md) | not reported | [0.39](/filings/0001401257-26-000034.md) |
| Basic EPS | $ per share | [(0.64)](/filings/0001401257-24-000121.md) | [0.78](/filings/0001401257-24-000135.md) | not reported | [(0.85)](/filings/0001401257-25-000061.md) | [(0.54)](/filings/0001401257-25-000089.md) | [(1.20)](/filings/0001401257-25-000108.md) | not reported | [0.09](/filings/0001401257-26-000034.md) | [0.62](/filings/0001401257-25-000089.md) | [(1.76)](/filings/0001401257-25-000108.md) | not reported | [0.40](/filings/0001401257-26-000034.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | period not labelled (2024-11-08) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [37.2](/filings/0001401257-23-000088.md) | [46.2](/filings/0001401257-25-000012.md) | [48.5](/filings/0001401257-24-000089.md) | [31.8](/filings/0001401257-24-000121.md) | [33.3](/filings/0001401257-24-000135.md) | [10.2](/filings/0001401257-26-000015.md) | [44.7](/filings/0001401257-26-000015.md) | [31.1](/filings/0001401257-25-000061.md) | [39.0](/filings/0001401257-25-000089.md) | [31.7](/filings/0001401257-25-000108.md) | [34.7](/filings/0001401257-26-000034.md) | [37.5](/filings/0001401257-26-000034.md) |
| Current assets | $m | [531](/filings/0001401257-23-000088.md) | [530](/filings/0001401257-25-000012.md) | [547](/filings/0001401257-24-000089.md) | [521](/filings/0001401257-24-000121.md) | [524](/filings/0001401257-24-000135.md) | not reported | [496](/filings/0001401257-26-000015.md) | [479](/filings/0001401257-25-000061.md) | [488](/filings/0001401257-25-000089.md) | [459](/filings/0001401257-25-000108.md) | [449](/filings/0001401257-26-000034.md) | [464](/filings/0001401257-26-000034.md) |
| Total assets | $m | [829](/filings/0001401257-23-000088.md) | [821](/filings/0001401257-25-000012.md) | [1,021](/filings/0001401257-24-000089.md) | [977](/filings/0001401257-24-000121.md) | [974](/filings/0001401257-24-000135.md) | not reported | [816](/filings/0001401257-26-000015.md) | [790](/filings/0001401257-25-000061.md) | [810](/filings/0001401257-25-000089.md) | [770](/filings/0001401257-25-000108.md) | [752](/filings/0001401257-26-000034.md) | [763](/filings/0001401257-26-000034.md) |
| Current liabilities | $m | [208](/filings/0001401257-23-000088.md) | [204](/filings/0001401257-25-000012.md) | [193](/filings/0001401257-24-000089.md) | [194](/filings/0001401257-24-000121.md) | [271](/filings/0001401257-24-000135.md) | not reported | [202](/filings/0001401257-26-000015.md) | [195](/filings/0001401257-25-000061.md) | [202](/filings/0001401257-25-000089.md) | [210](/filings/0001401257-25-000108.md) | [207](/filings/0001401257-26-000034.md) | [209](/filings/0001401257-26-000034.md) |
| Total liabilities | $m | [412](/filings/0001401257-23-000088.md) | [408](/filings/0001401257-25-000012.md) | [575](/filings/0001401257-24-000089.md) | [535](/filings/0001401257-24-000121.md) | [530](/filings/0001401257-24-000135.md) | not reported | [496](/filings/0001401257-26-000015.md) | [470](/filings/0001401257-25-000061.md) | [476](/filings/0001401257-25-000089.md) | [473](/filings/0001401257-25-000108.md) | [461](/filings/0001401257-26-000034.md) | [482](/filings/0001401257-26-000034.md) |
| Long-term debt | $m | [129](/filings/0001401257-23-000088.md) | [130](/filings/0001401257-25-000012.md) | [282](/filings/0001401257-24-000089.md) | [246](/filings/0001401257-24-000121.md) | [162](/filings/0001401257-24-000135.md) | not reported | [187](/filings/0001401257-26-000015.md) | [170](/filings/0001401257-25-000061.md) | [158](/filings/0001401257-25-000089.md) | [139](/filings/0001401257-25-000108.md) | [135](/filings/0001401257-26-000034.md) | [152](/filings/0001401257-26-000034.md) |
| Current portion of debt | $m | [1.1](/filings/0001401257-23-000088.md) | [1.2](/filings/0001401257-25-000012.md) | [5.2](/filings/0001401257-24-000089.md) | [6.5](/filings/0001401257-24-000121.md) | [69.4](/filings/0001401257-24-000135.md) | not reported | [1.9](/filings/0001401257-26-000015.md) | [1.8](/filings/0001401257-25-000061.md) | [1.7](/filings/0001401257-25-000089.md) | [1.4](/filings/0001401257-25-000108.md) | [1.4](/filings/0001401257-26-000034.md) | [1.4](/filings/0001401257-26-000034.md) |
| Shareholders' equity | $m | [417](/filings/0001401257-24-000135.md) | [413](/filings/0001401257-26-000015.md) | [446](/filings/0001401257-25-000108.md) | [442](/filings/0001401257-25-000108.md) | [444](/filings/0001401257-25-000108.md) | not reported | [320](/filings/0001401257-26-000034.md) | [320](/filings/0001401257-26-000034.md) | [334](/filings/0001401257-25-000108.md) | [297](/filings/0001401257-25-000108.md) | [291](/filings/0001401257-26-000034.md) | [281](/filings/0001401257-26-000034.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(6.4) d](/filings/0001401257-24-000121.md) | [26.4 d](/filings/0001401257-24-000135.md) | [11.3 d](/filings/0001401257-25-000012.md) | [5.0](/filings/0001401257-25-000061.md) | [23.1 d](/filings/0001401257-25-000089.md) | [25.6 d](/filings/0001401257-25-000108.md) | [38.5 d](/filings/0001401257-26-000015.md) | [9.3](/filings/0001401257-26-000034.md) | [15.8 d](/filings/0001401257-25-000089.md) | [22.9 d](/filings/0001401257-25-000108.md) | [22.4 d](/filings/0001401257-26-000015.md) | [1.6](/filings/0001401257-26-000034.md) |
| Capital expenditure | $m | [1.7 d](/filings/0001401257-24-000121.md) | [2.7 d](/filings/0001401257-24-000135.md) | [2.4 d](/filings/0001401257-25-000012.md) | [2.9](/filings/0001401257-25-000061.md) | [1.5 d](/filings/0001401257-25-000089.md) | [1.3 d](/filings/0001401257-25-000108.md) | [2.4 d](/filings/0001401257-26-000015.md) | [2.1](/filings/0001401257-26-000034.md) | [1.0 d](/filings/0001401257-25-000089.md) | [1.4 d](/filings/0001401257-25-000108.md) | [1.6 d](/filings/0001401257-26-000015.md) | [0.3](/filings/0001401257-26-000034.md) |
| Share repurchases | $m | [0.0 d](/filings/0001401257-24-000121.md) | [0.0 d](/filings/0001401257-24-000135.md) | [2.5 d](/filings/0001401257-25-000012.md) | [0.0](/filings/0001401257-25-000061.md) | [0.0 d](/filings/0001401257-25-000089.md) | [0.0 d](/filings/0001401257-25-000108.md) | [0.0 d](/filings/0001401257-26-000015.md) | [2.0](/filings/0001401257-26-000034.md) | [4.3 d](/filings/0001401257-25-000089.md) | [14.8 d](/filings/0001401257-25-000108.md) | [13.5 d](/filings/0001401257-26-000015.md) | [4.6](/filings/0001401257-26-000034.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [10.5](/filings/0001401257-23-000069.md) | [10.6](/filings/0001401257-23-000088.md) | [10.2](/filings/0001401257-24-000089.md) | [10.2](/filings/0001401257-24-000121.md) | [10.4](/filings/0001401257-24-000135.md) | [12.2](/filings/0001401257-25-000061.md) | [12.3](/filings/0001401257-25-000089.md) | [12.3](/filings/0001401257-25-000108.md) | [12.6](/filings/0001401257-26-000034.md) | [12.6](/filings/0001401257-25-000089.md) | [11.7](/filings/0001401257-25-000108.md) | [11.6](/filings/0001401257-26-000034.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 11,304,286 at 2026-04-24, from the cover of the [10-Q filed 2026-05-01](/filings/0001401257-26-000034.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. No prices; not investment advice.